XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
XORTX Therapeutics Inc. reported a decrease in total assets to $3.85 million as of September 30, 2024, compared to $5.47 million at the end of 2023, alongside an increased derivative warrant liability. The company’s current liabilities rose significantly, highlighting financial challenges amid ongoing research and development expenses.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
